关注
Daniel Zips
Daniel Zips
Radiation Oncology Charite Berlin
在 charite.de 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Radiation oncology in the era of precision medicine
M Baumann, M Krause, J Overgaard, J Debus, SM Bentzen, J Daartz, ...
Nature Reviews Cancer 16 (4), 234-249, 2016
8322016
Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer
D Zips, K Zöphel, N Abolmaali, R Perrin, A Abramyuk, R Haase, S Appold, ...
Radiotherapy and Oncology 105 (1), 21-28, 2012
394*2012
Glycolytic metabolism and tumour response to fractionated irradiation
UGA Sattler, SS Meyer, V Quennet, C Hoerner, H Knoerzer, C Fabian, ...
Radiotherapy and oncology 94 (1), 102-109, 2010
2532010
CD 8+ tumour‐infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre …
P Balermpas, F Rödel, C Rödel, M Krause, A Linge, F Lohaus, ...
International journal of cancer 138 (1), 171-181, 2016
2312016
Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice
V Quennet, A Yaromina, D Zips, A Rosner, S Walenta, M Baumann, ...
Radiotherapy and Oncology 81 (2), 130-135, 2006
2312006
A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
S Leger, A Zwanenburg, K Pilz, F Lohaus, A Linge, K Zöphel, J Kotzerke, ...
Scientific reports 7 (1), 13206, 2017
2262017
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation
A Yaromina, M Krause, H Thames, A Rosner, M Krause, F Hessel, ...
Radiotherapy and oncology 83 (3), 304-310, 2007
1752007
New anticancer agents: in vitro and in vivo evaluation
D Zips, HD Thames, M Baumann
in vivo 19 (1), 1-7, 2005
1722005
Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell …
M Baumann, T Herrmann, R Koch, W Matthiessen, S Appold, B Wahlers, ...
Radiotherapy and Oncology 100 (1), 76-85, 2011
1662011
HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a …
F Lohaus, A Linge, I Tinhofer, V Budach, E Gkika, M Stuschke, ...
Radiotherapy and oncology 113 (3), 317-323, 2014
1632014
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
U Nestle, T Schimek-Jasch, S Kremp, A Schaefer-Schuler, M Mix, ...
The Lancet Oncology 21 (4), 581-592, 2020
1552020
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary …
A Linge, F Lohaus, S Löck, A Nowak, V Gudziol, C Valentini, ...
Radiotherapy and Oncology 121 (3), 364-373, 2016
1532016
Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging
S Löck, R Perrin, A Seidlitz, A Bandurska-Luque, S Zschaeck, K Zöphel, ...
Radiotherapy and Oncology 124 (3), 533-540, 2017
1482017
Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV (−) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG
A Linge, S Löck, V Gudziol, A Nowak, F Lohaus, C von Neubeck, M Jütz, ...
Clinical cancer research 22 (11), 2639-2649, 2016
1332016
Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial
S Welz, D Mönnich, C Pfannenberg, K Nikolaou, M Reimold, ...
Radiotherapy and Oncology 124 (3), 526-532, 2017
1272017
Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets
T Skripcak, C Belka, W Bosch, C Brink, T Brunner, V Budach, D Büttner, ...
Radiotherapy and Oncology 113 (3), 303-309, 2014
1262014
Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlateswith reoxygenation
C Petersen, D Zips, M Krause, K Schöne, W Eicheler, C Hoinkis, ...
International Journal of Radiation Oncology* Biology* Physics 51 (2), 483-493, 2001
1252001
Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in …
A Yaromina, D Zips, HD Thames, W Eicheler, M Krause, A Rosner, ...
Radiotherapy and oncology 81 (2), 122-129, 2006
1242006
Cancer stem cells and radiotherapy
M Baumann, M Krause, H Thames, K Trott, D Zips
International journal of radiation biology 85 (5), 391-402, 2009
1192009
Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis
A Jakobi, A Bandurska-Luque, K Stützer, R Haase, S Löck, LJ Wack, ...
International Journal of Radiation Oncology* Biology* Physics 92 (5), 1165-1174, 2015
1172015
系统目前无法执行此操作,请稍后再试。
文章 1–20